Nationally, only about 5 percent of patients enrolled in clinical trials are minorities. Georgia CaRES (Georgia Cancer Research) is helping to change that paradigm. Georgia CaRES is a National Cancer Center-funded initiative—one of only 12 nationally—that aims to provide minority and underserved cancer patients with more access to the latest cancer clinical trials and treatments, right in their own communities.
While discoveries start in a basic science lab, clinical trials are where the laboratory findings are translated to see how they can improve the treatment of cancer in patients. Clinical trials offer patients not only the standard of care chemotherapy but also the possibility of receiving treatment that could be more beneficial in the future. According to the NCI, the overall goal of NCORP is to bring cancer clinical research studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities. Cancer care delivery studies look at the success and cost-efficiency of current cancer care practices.
The Georgia CaRES partnership network includes: Augusta Oncology Associates, DeKalb Medical Center in Decatur, Georgia Cancer Center in Augusta, Phoebe Putney Memorial Hospital in Albany, Morehouse School of Medicine in Atlanta and University Cancer & Blood Center, LLC in Athens.
The network also offers national pediatric cancer clinical trials right here in the state along with trials to help improve how cancer care is delivered.
Since 1994, the Georgia Cancer Center has led a partnership network focusing on bringing the latest cancer therapies to minorities and underserved patients. Most recently, the National Cancer Institute has provided the Georgia Cancer Center with a five-year grant to lead Georgia CaRES (Georgia Cancer Research), as part of its Community Oncology Program (NCORP). The program is one of just 12 selected nationally and the state’s only minority/underserved cancer research program. The program brings clinical trials—previously available only at large academic medical centers—to community settings, which is where most cancer patients receive treatment.
According to the NCI, the five-year grants go to institutions and organizations that will ensure the latest scientific discoveries are translated into the most effective strategies to prevent, diagnose and treat cancer. As a Minority/Underserved Community Site of the NCI Community Oncology Research Program (NCORP) network, Georgia CaRES:
Georgia CaRES helps make available clinical trials for every type of cancer in both children and adults. Along with pharmacological trials offering the latest drug therapies, one-quarter of the Georgia CaRES trials focus on health care delivery. These trials examine how to improve cancer prevention, screening and symptom management, among other goals.
Thanks to clinical trials, patients have access to treatments that may be better than the current standard of care. In most parts of the United States, these types of treatments may only be offered at large cancer centers, but Georgia CaRES ensures these innovative care options are available right here in our state at community health centers, which are where the majority of cancer patients seek care.
It’s also important to realize that typically, minority patients make up only 5 percent of those enrolled in clinical trials. Thanks to Georgia CaRES, the minority accrual rate of its partnership network — which covers two-thirds of the state — is 45 percent. This means that more patients who need these treatments are able to benefit. As a result, Georgia CaRES is overcoming historic barriers that have stood in the way of minority and underserved cancer patients by opening up new opportunities to participate in clinical trials and other important cancer research.
The Georgia Cancer Center at Augusta University has been awarded a six-year $6 million grant from the National Cancer Institute (NCI) to lead a statewide initiative that improves access to innovative clinical trials for a variety of cancers to underserved individuals across Georgia. In her new role, Dr. Martha S. Tingen will work to build a cancer prevention and control research program to assess the impact of healthier lifestyle choices on reducing preventable cancer deaths in the region. The Georgia Cancer Center at Augusta University is one of 12 sites in the country to receive a National Cancer Institute grant to improve access to clinical trials for minorities and those living in rural communities. Dr. Sharad Ghamande and one of his patients sat down with Shaquille Lord, a reporter for Fox 54, to […] The Georgia Cancer Center at Augusta University is one of a dozen sites across the nation helping build a molecular profile of six cancers that often strike early and disparately.
Continue reading Georgia Cancer Center receives $6 million grant to improve access to clinical trials in minority/underserved communities
Georgia Cancer Center receives $6 million grant to improve access to clinical trials in minority/underserved communities
Continue reading Georgia Cancer Center creates new position tasked with helping people make healthy life choices
Georgia Cancer Center creates new position tasked with helping people make healthy life choices
Continue reading Working to improve access to care for cancer patients in rural communities
Working to improve access to care for cancer patients in rural communities
Continue reading Georgia Cancer Center participates in initiative to understand racial, ethnic, age disparities in six cancers
Georgia Cancer Center participates in initiative to understand racial, ethnic, age disparities in six cancers
Georgia CaRES
Geri K. Whitaker, BS
Project Coordinator
Georgia Cancer Center
1120 15th Street, CN-3151
Augusta, GA 30912
(706) 721-2388
(706) 721-0101
